Kite Pharma, Inc. Deferred Revenue (Non-Current)
Kite Pharma, Inc. had Deferred Revenue (Non-Current) of $78.35 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2017-08-08
- 2017-06-30: Deferred Revenue, Noncurrent $78.35M.
- 2017-03-31: Deferred Revenue, Noncurrent $38.18M.
- 2016-12-31: Deferred Revenue, Noncurrent $19.78M.
- 2016-09-30: Deferred Revenue, Noncurrent $22.46M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2017-06-30 | $78.35M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $38.18M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $19.78M 10-Q · filed 2017-08-08 |
| 2016-09-30 | $22.46M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $25.14M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $28.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $32.18M 10-K · filed 2017-02-28 |
| 2015-09-30 | $35.88M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $39.08M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $42.45M 10-Q · filed 2015-05-15 |